Skip to content
CNS Pulse
PipelineIndicationsCompaniesTargetsReadoutsConferencesAbstractsAuthors
  1. Home
  2. Pipeline
  3. Milsaperidone (VHX-896)
  4. Bysanti

Brand name · Small Molecule

Bysanti

Bysanti is a brand name for Milsaperidone (VHX-896), developed by Vanda Pharmaceuticals Inc..

Status
Phase 3 for Major depressive disorder
Mechanism
5-HT2A Antagonist
Developer
Vanda Pharmaceuticals Inc.

Programs

  • Milsaperidone (VHX-896) for Major depressive disorderPhase 3Active
  • Milsaperidone (VHX-896) for Bipolar disorderApprovedApproved

Also known as

  • VHX-896
  • P-88-8991
  • milsaperidone
  • (S)-hydroxy iloperidone
  • 501373-88-2

View the full Milsaperidone (VHX-896) profile →

CNS Pulse

© 2026 CNS Pulse · Psychopharmacology pipeline intelligence & conference reports.